These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6713348)
21. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital. Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341 [TBL] [Abstract][Full Text] [Related]
22. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229 [TBL] [Abstract][Full Text] [Related]
23. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Meyer JS; Province MA Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of estrogen receptors in primary breast cancer. Hähnel R; Woodings T; Vivian AB Cancer; 1979 Aug; 44(2):671-5. PubMed ID: 476576 [TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival. Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602 [TBL] [Abstract][Full Text] [Related]
26. Breast cancer without axillary metastases. Are there high-risk biologic subpopulations? Sears HF; Janus C; Levy W; Hopson R; Creech R; Grotzinger P Cancer; 1982 Nov; 50(9):1820-7. PubMed ID: 7116307 [TBL] [Abstract][Full Text] [Related]
27. Oestrogen receptors and survival in early breast cancer. Croton R; Cooke T; Holt S; George WD; Nicolson R; Griffiths K Br Med J (Clin Res Ed); 1981 Nov; 283(6302):1289-91. PubMed ID: 6794823 [TBL] [Abstract][Full Text] [Related]
28. Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Raemaekers JM; Beex LV; Koenders AJ; Pieters GF; Smals AG; Benraad TJ; Kloppenborg PW Breast Cancer Res Treat; 1985; 6(2):123-30. PubMed ID: 4052639 [TBL] [Abstract][Full Text] [Related]
29. [Follow-up of node-negative patients with breast cancer]. Meinen K; Weih EH Zentralbl Gynakol; 1989; 111(1):19-28. PubMed ID: 2922974 [TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group. Kinne DW; Butler JA; Kimmel M; Flehinger BJ; Menendez-Botet C; Schwartz M Arch Surg; 1987 Nov; 122(11):1303-6. PubMed ID: 3675194 [TBL] [Abstract][Full Text] [Related]
31. Estrogen receptors and the pattern of relapse in breast cancer. Qazi R; Chuang JL; Drobyski W Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the steroid receptor content in primary breast cancer. von Maillot K; Horke W; Prestele H Arch Gynecol; 1982; 231(3):185-90. PubMed ID: 7125700 [TBL] [Abstract][Full Text] [Related]
33. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880 [TBL] [Abstract][Full Text] [Related]
34. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients. van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438 [TBL] [Abstract][Full Text] [Related]
35. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery]. Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761 [No Abstract] [Full Text] [Related]
36. Radiation therapy following mastectomy for axillary node-positive breast cancer: indication of chest wall irradiation. Ogawa K; Toita T; Kakinohana Y; Adachi G; Nishikuramori Y; Kamada Y; Miyaguni T; Shimabukuro K; Tamaki N; Murayama S Oncol Rep; 2000; 7(5):1107-12. PubMed ID: 10948347 [TBL] [Abstract][Full Text] [Related]
38. Association between prognosis and hormone receptors in women with breast cancer. Papatestas AE; Miller SR; Pertsemlidis D; Fagerstrom R; Lesnick G; Aufses AH Cancer Detect Prev; 1986; 9(3-4):303-10. PubMed ID: 3742506 [TBL] [Abstract][Full Text] [Related]
39. Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status. Pegoraro RJ; Nirmul D; Reinach SG; Jordaan JP; Joubert SM Breast Cancer Res Treat; 1986; 7(2):111-8. PubMed ID: 3719113 [TBL] [Abstract][Full Text] [Related]
40. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer. Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]